{"product_id":"hi-tech-pharmaceuticals-slimagovy-180-tablets","title":"Hi-Tech Pharmaceuticals - SlimaGovy - 180 Tablets","description":"\u003cp\u003eHi-Tech Pharmaceuticals Slimgovy® (formerly Slimaglutide®) is a stimulant-free, natural GLP-1 support formula built around Cyclosome® Berberine and 10 Glucagon-like Peptide-1 (GLP-1) receptor agonists and secretagogues — botanical and plant-derived compounds that activate the body's own GLP-1 production pathway for appetite regulation, blood sugar metabolism support, and healthy weight management. The formula centers on three proprietary Hi-Tech branded compounds: Nexrutine XS® (97% pure berberine from Phellodendron bark with 10x improved bioavailability via Cyclosome delivery), YGDPure® (a clinically studied GLP-1 pathway extract — a 45-day clinical trial documented an average 11.2 lbs of weight loss versus 0.7 lbs in the placebo group), and TwinCretin® (a Fagonia Cretia extract that simultaneously stimulates both GLP-1 and GIP secretion — the same dual-hormone mechanism targeted by pharmaceutical tirzepatide). Plus Glucozene®-Rx Momordica Charantia extract, Lagerstroemia Speciosa leaf extract, and five additional GLP-1 agonist and secretagogue compounds. Zero caffeine. Zero stimulants. Not a pharmaceutical GLP-1 drug. 180 tablets — 30-day supply. Take 3 tablets with 4oz or less of water twice daily on an empty stomach. Consult a physician before use if taking diabetes medications, blood pressure medications, or any prescription drugs. California Prop 65 Warning applies.†\u003c\/p\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eSupplement Facts — Hi-Tech Pharmaceuticals Slimgovy® (Per 3 Tablets \/ Twice Daily \/ 180 Tablets \/ 30 Days)\u003c\/h2\u003e\n\n\u003ch3\u003eGLP-1 and GIP Agonist and Secretagogue Complex — 10 Compounds\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNexrutine XS® Berberine (from Phellodendron bark, 97% pure)\u003c\/strong\u003e — via Cyclosome® delivery: 10x improved bioavailability, retention time extended from 30-45 minutes to over 10 hours\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYGDPure® (Yerba\/Gymnema\/Dolichos extract)\u003c\/strong\u003e — GLP-1 pathway activation; 45-day clinical trial: 11.2 lbs average weight loss vs 0.7 lbs placebo\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTwinCretin® (Fagonia Cretia extract)\u003c\/strong\u003e — dual GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide) secretion stimulation; upregulates proglucagon, GIP, and prohormone convertase gene expression\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLagerstroemia Speciosa Leaf Extract — 180mg\u003c\/strong\u003e (standardized to 5% Corosolic Acid, Ellagic Acid, Gallotannins, and Pentagalloylglucose)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlucozene®-Rx Momordica Charantia Extract (fruit)\u003c\/strong\u003e (standardized to 5% Charantin, Polypeptide-P)\u003c\/li\u003e\n  \u003cli\u003ePlus five additional GLP-1 agonist and secretagogue botanical compounds\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cul\u003e\n  \u003cli\u003eOther Ingredients: Microcrystalline Cellulose, Phosphatidylcholine 75%, Sodium Caprylate, MCT Oil, Phytosterols, Magnesium Stearate, FD\u0026amp;C Yellow #5 Lake, Silica, FD\u0026amp;C Yellow #6 Lake\u003c\/li\u003e\n  \u003cli\u003eDelivery systems: Cyclosome® Technology + SEDD® (Self-Emulsifying Drug Delivery) + SNAC® Technology + Sodium Caprate (C10 MCT for GI comfort and absorption)\u003c\/li\u003e\n  \u003cli\u003eZero caffeine. Zero stimulants. No adrenergic compounds.\u003c\/li\u003e\n  \u003cli\u003e180 tablets — 30-day supply at 3 tablets twice daily\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eTake 3 tablets with 4oz or LESS of water twice daily on an empty stomach\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003eTake first dose in the morning and second dose in the afternoon\u003c\/li\u003e\n  \u003cli\u003eWait 15 minutes after taking before drinking additional water\u003c\/li\u003e\n  \u003cli\u003eFormerly known as Slimaglutide®\u003c\/li\u003e\n  \u003cli\u003eNot a pharmaceutical GLP-1 receptor agonist drug\u003c\/li\u003e\n  \u003cli\u003eConsult a physician before use if taking diabetes medications, blood pressure medications, or any prescription drugs\u003c\/li\u003e\n  \u003cli\u003eNot for pregnant or nursing women\u003c\/li\u003e\n  \u003cli\u003eCalifornia Prop 65 Warning applies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eSlimgovy vs. Pharmaceutical GLP-1 Drugs — The Honest Comparison\u003c\/h2\u003e\n\n\u003cp\u003eOzempic (semaglutide), Wegovy (semaglutide), Mounjaro and Zepbound (tirzepatide) are prescription injectable GLP-1 receptor agonist medications — they directly bind GLP-1 receptors throughout the body at pharmacological concentrations, producing powerful appetite suppression, delayed gastric emptying, and significant weight loss (15-22% of body weight in the strongest clinical trials). They require a physician prescription, weekly self-injection, and carry a documented side effect profile including nausea, vomiting, constipation, gastroparesis, potential pancreatitis, and muscle mass loss alongside fat reduction.†\u003c\/p\u003e\n\n\u003cp\u003eSlimgovy® is a dietary supplement — not a pharmaceutical drug. It contains botanical compounds that activate the body's natural GLP-1 production through intestinal L-cell stimulation and GIP pathway activation, rather than directly binding GLP-1 receptors at pharmacological levels. The effect size is meaningfully smaller than pharmaceutical GLP-1 agonists. The side effect profile is substantially more favorable. The cost is a fraction of prescription GLP-1 medications. For individuals who are not candidates for prescription GLP-1 drugs, cannot access them, or prefer a natural supplemental approach to metabolic support, Slimgovy® is one of the most comprehensively formulated non-pharmaceutical GLP-1 support products available — but it is not a pharmaceutical equivalent and should not be marketed as one.†\u003c\/p\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eThe Science Behind Slimgovy® — Three Primary Innovations\u003c\/h2\u003e\n\n\u003ch3\u003eInnovation 1 — Nexrutine XS® Berberine with Cyclosome® Delivery\u003c\/h3\u003e\n\n\u003cp\u003eBerberine is one of the most extensively researched natural compounds for blood glucose management and metabolic health — with multiple meta-analyses documenting effects comparable to Metformin (the world's most prescribed diabetes medication) for blood sugar control, insulin sensitivity, and body weight in Type 2 diabetes and pre-diabetic subjects. Berberine activates AMPK (AMP-Activated Protein Kinase — the same enzyme Metformin targets), reducing hepatic glucose production, improving insulin receptor sensitivity, and driving glucose uptake into muscle cells.†\u003c\/p\u003e\n\n\u003cp\u003eThe fundamental problem with standard berberine is bioavailability. Raw berberine is rapidly degraded by intestinal enzymes and subject to P-glycoprotein efflux pumps — resulting in extremely poor oral bioavailability (typically less than 5% of the dose reaching systemic circulation intact). A berberine Pharmacokinetic study on Hi-Tech's Nexrutine XS® Berberine documented improved bioavailability (AUC) of over 10 times on a molar basis compared to standard berberine, with retention time extended from 30-45 minutes to over 10 hours. Nexrutine XS® is a 97% pure berberine extract from Phellodendron bark — the highest commercial purity available. Delivered through Cyclosome® Technology (HPBCD + Phosphatidylcholine 75%) with additional SEDD (Self-Emulsifying Drug Delivery) and Sodium Caprate (C10 MCT for GI comfort), this is the most bioavailable berberine formulation Hi-Tech has produced.†\u003c\/p\u003e\n\n\u003ch3\u003eInnovation 2 — YGDPure® and the 45-Day Clinical Trial\u003c\/h3\u003e\n\n\u003cp\u003eYGDPure® is Hi-Tech's proprietary extract combining Yerba Mate, Gymnema Sylvestre, and Dolichos biflorus — a combination shown to work through the GLP-1 pathway among multiple mechanisms for appetite and weight regulation. The specific clinical trial referenced in Hi-Tech's documentation is a 45-day randomized trial in which subjects taking the YGD formulation lost an average of 11.2 lbs while the placebo group lost an average of 0.7 lbs — a statistically meaningful difference driven by appetite regulation and metabolic effects from the GLP-1 pathway activation. Gymnema Sylvestre specifically has decades of traditional use and modern clinical documentation for blood sugar support — it reduces intestinal glucose absorption and has been shown to reduce sweet food cravings through interaction with taste receptors. Yerba Mate provides a modest caffeine contribution (accounted for in the formula's overall profile) alongside its chlorogenic acids and other bioactive metabolites.†\u003c\/p\u003e\n\n\u003ch3\u003eInnovation 3 — TwinCretin® and Dual GLP-1\/GIP Activation\u003c\/h3\u003e\n\n\u003cp\u003eTwinCretin® is perhaps the most scientifically sophisticated component of Slimgovy® — a proprietary Fagonia Cretia extract that Hi-Tech's research team found stimulates both GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide) secretion simultaneously. The dual-incretin mechanism is significant because it mirrors the pharmacological approach of tirzepatide (Mounjaro\/Zepbound) — the pharmaceutical that targets both GLP-1 and GIP receptors simultaneously, producing the most potent weight loss results of any currently approved drug. GLP-1 governs appetite suppression and insulin-stimulated glucose disposal. GIP governs insulin secretion efficiency and fat metabolism. Their combined activation produces synergistic metabolic benefits that GLP-1 activation alone doesn't achieve.†\u003c\/p\u003e\n\n\u003cp\u003eTwinCretin® is documented to increase cellular hormone content of GLP-1 and GIP, and to upregulate the gene expression of proglucagon, GIP, and prohormone convertase — the genes that govern the production of incretin hormones in intestinal L-cells and K-cells. This gene expression upregulation means more hormone-producing cells operating at higher output, rather than simply acutely stimulating existing hormone release. The long-term implication is that consistent Slimgovy® use may produce progressively stronger GLP-1\/GIP support as gene expression adapts.†\u003c\/p\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eThe Additional GLP-1 Agonist Compounds\u003c\/h2\u003e\n\n\u003ch3\u003eLagerstroemia Speciosa (Banaba Leaf) — 180mg\u003c\/h3\u003e\n\n\u003cp\u003eBanaba Leaf extract standardized to 5% Corosolic Acid, Ellagic Acid, Gallotannins, and Pentagalloylglucose covers multiple glucose metabolism mechanisms. Corosolic Acid activates GLUT4 glucose transporters independently of insulin — directly facilitating cellular glucose uptake without requiring insulin signaling. Ellagic Acid inhibits alpha-glucosidase (reducing post-meal glucose absorption from carbohydrates). Pentagalloylglucose has documented anti-obesity activity through adipogenesis inhibition. Multiple clinical studies on Banaba extract have documented significant post-meal blood glucose reductions within 60 minutes — particularly relevant taken before meals as the Slimgovy® dosing protocol specifies.†\u003c\/p\u003e\n\n\u003ch3\u003eGlucozene®-Rx Momordica Charantia (Bitter Melon) Extract\u003c\/h3\u003e\n\n\u003cp\u003eMomordica Charantia (Bitter Melon) standardized to 5% Charantin and Polypeptide-P is one of the most studied traditional anti-diabetic botanicals in Asian medicine. Charantin activates AMPK and improves glucose utilization in adipose and muscle tissue. Polypeptide-P is a plant-derived insulin analog that stimulates glucose uptake through mechanisms similar to insulin. The Glucozene®-Rx branded extract ensures standardized content of both primary bioactive fractions at therapeutic concentrations.†\u003c\/p\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eThe Unique Dosing Protocol — Why 4oz or Less of Water Matters\u003c\/h2\u003e\n\n\u003cp\u003eSlimgovy® has a specific and non-negotiable dosing instruction: take 3 tablets with 4oz or LESS of water on an empty stomach. Wait 15 minutes before drinking more water. This unusual restriction relates directly to the delivery system. Slimgovy® uses SEDD (Self-Emulsifying Drug Delivery) and SNAC (Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) technology alongside Sodium Caprate (C10 MCT) to facilitate absorption of the berberine and botanical compounds through the intestinal epithelium. Excessive water at the time of dosing dilutes these delivery agents and reduces their ability to maintain the emulsion that drives absorption. The 4oz or less instruction is mechanistically driven — following it is essential for maximizing the bioavailability advantages that the delivery system provides. This is confirmed by user reports: following the protocol produces noticeably stronger appetite suppression than ignoring it.†\u003c\/p\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eIs Slimgovy® the same product as Slimaglutide®?\u003c\/strong\u003e\u003cbr\u003e\n    Yes — Slimgovy® was formerly marketed as Slimaglutide®. Hi-Tech rebranded the product, but the formula is the same. The Cyclosome Berberine, YGDPure®, TwinCretin®, Lagerstroemia Speciosa, and Glucozene®-Rx Momordica Charantia are all present in the current Slimgovy® formula. Both names refer to the same product with a name change only.†\n  \u003c\/li\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eCan Slimgovy® be taken with prescription diabetes medications?\u003c\/strong\u003e\u003cbr\u003e\n    No — not without physician guidance. Slimgovy® contains berberine (AMPK activator with glucose-lowering effects comparable to Metformin), Banaba Leaf extract (GLUT4 activator), Bitter Melon (insulin-analog activity), and GLP-1 stimulating compounds — all of which lower blood glucose through different mechanisms. Combining these with prescription diabetes medications (Metformin, sulfonylureas, insulin, SGLT2 inhibitors, or GLP-1 receptor agonists) risks hypoglycemia from compounded glucose-lowering effects. Physician consultation before use is mandatory for anyone on diabetes medication.†\n  \u003c\/li\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eWhy must Slimgovy® be taken with 4oz or less of water?\u003c\/strong\u003e\u003cbr\u003e\n    The SEDD (Self-Emulsifying Drug Delivery) and SNAC delivery systems in Slimgovy® require a specific gastric environment to form the emulsion that drives absorption of berberine and botanical compounds through the intestinal epithelium. Excessive water dilutes the delivery agents, disrupting the emulsion formation and reducing bioavailability. The 15-minute water restriction after dosing allows the delivery system to fully establish before stomach contents are diluted. This is not optional — following the protocol is essential for the formula to work at its documented efficacy.†\n  \u003c\/li\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eHow long before I see results from Slimgovy®?\u003c\/strong\u003e\u003cbr\u003e\n    The appetite suppression effect from the GLP-1 activation is typically noticed within the first 1-2 weeks — reduced hunger, reduced cravings, improved satiety after smaller meals. The metabolic and blood sugar effects from the berberine component develop over 4-8 weeks of consistent use. Weight loss results depend on dietary compliance alongside Slimgovy® use — the product supports appetite regulation and metabolic health, but a caloric deficit from diet is still required for meaningful fat loss. The 45-day YGDPure® clinical trial showing 11.2 lbs average weight loss reflects results during a structured diet program.†\n  \u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eHow to Take Hi-Tech Pharmaceuticals Slimgovy®\u003c\/h2\u003e\n\u003cp\u003eTake 3 tablets with 4oz or LESS of cold water twice daily on an empty stomach. Take first dose in the morning before breakfast. Take second dose in the afternoon before a meal. Wait 15 minutes after taking before drinking additional water. Do not take with a full glass of water — the delivery system requires limited water volume for optimal absorption. Do not take with food — empty stomach absorption is essential for the SEDD and Cyclosome delivery systems to function effectively. Zero caffeine — can be taken at any time of day without sleep disruption. Do not combine with prescription diabetes medications without physician clearance. Do not combine with other GLP-1 support supplements that may compound blood glucose-lowering effects. Not for pregnant or nursing women. Not for persons under 18. Consult a physician before use if taking any prescription medications. California Prop 65 Warning applies.†\u003c\/p\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eWhy Buy at Get Yok'd\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eReal-time inventory across all five Southern California stores\u003c\/li\u003e\n  \u003cli\u003eAvailable in \u003cstrong\u003eBurbank, Glendale, Glendale Galleria, Pasadena, and North Hollywood\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eAuthorized Hi-Tech Pharmaceuticals retailer — carrying the full Hi-Tech weight management lineup\u003c\/li\u003e\n  \u003cli\u003eStaff who can walk you through Slimgovy® and how it fits alongside other Hi-Tech metabolic and fat loss products\u003c\/li\u003e\n  \u003cli\u003eOne of the best loyalty programs in the supplement industry — earn rewards on every purchase\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003chr\u003e\n\n\u003ch2\u003eWho Should Exercise Caution with Slimgovy®\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eIndividuals taking any diabetes medications (Metformin, insulin, sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists) must consult a physician before use — compounded blood glucose-lowering effects risk hypoglycemia\u003c\/li\u003e\n  \u003cli\u003eIndividuals taking blood pressure medications should consult a physician — Berberine has documented blood pressure-lowering effects that may compound antihypertensive medications\u003c\/li\u003e\n  \u003cli\u003eIndividuals with thyroid conditions should consult a physician — Berberine affects thyroid hormone metabolism\u003c\/li\u003e\n  \u003cli\u003eIndividuals with gastroparesis should not use without physician clearance — GLP-1 pathway activation slows gastric emptying which may worsen gastroparesis\u003c\/li\u003e\n  \u003cli\u003eIndividuals taking any prescription medications metabolized by CYP3A4 enzymes should consult a physician — Berberine inhibits CYP3A4\u003c\/li\u003e\n  \u003cli\u003eNot for pregnant or nursing women\u003c\/li\u003e\n  \u003cli\u003eNot for persons under 18\u003c\/li\u003e\n  \u003cli\u003eConsult a physician before use if taking any prescription medications\u003c\/li\u003e\n  \u003cli\u003eCalifornia Prop 65 Warning applies.\u003c\/li\u003e\n  \u003cli\u003eKeep out of reach of children.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003e†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/em\u003e\u003c\/p\u003e","brand":"Hi-Tech Pharmaceuticals","offers":[{"title":"Default Title","offer_id":48929832567034,"sku":"210000012373","price":129.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1713\/7821\/files\/GETYOKD_HITECHPHARMA_SLIMAGOVY.webp?v=1779736420","url":"https:\/\/www.getyokd.com\/products\/hi-tech-pharmaceuticals-slimagovy-180-tablets","provider":"Get Yok'd Nutrition","version":"1.0","type":"link"}